Transparency Rules for Clinical Data Reporting
Transparency in clinical data reporting has become a central pillar of regulatory compliance and market credibility within the U.S. biotechnology sector. As clinical trials grow more complex and globally distributed, stakeholders, including regulators, investors, and patients, are demanding greater visibility into trial design, outcomes, and data integrity. This shift is not only ethical but also … Read more